pacritinib
cti biopharma
['#mpn', 'pacritinib', 'mpnsm']
#asco22 #mpnsm pettit: pacritinib is a selective jak2 inhibitor (spares jak1 and thus is less suppressive to platelet count) and also inhibits irak1. approved for mf with plts &lt;50k in 2/2022. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)